PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs

American Journal of Hematology

Volumn 71, Issue 2, 2002, Pages 89-93

  Balta, Gunay ^a   Altay, Cigdem ^a   Gurgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

4G 5G polymorphism; Genetic risk factor; Internal organ vessels; PAI 1 gene; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BINDING SITE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FULMINATING PURPURA; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PAI1 GENE; PORTAL VEIN; PRIORITY JOURNAL; PROMOTER REGION; RETINA DISEASE; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOSIS;

ADOLESCENT; ADULT; AGED; BLOOD VESSELS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PORTAL VEIN; PROMOTER REGIONS (GENETICS); RISK FACTORS; THROMBOSIS; TURKEY;

EID: 0036786916     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10192     Document Type: Article

References (16)

1. Kohler HP, Grant PJ. Mechanisms of disease: plasminogen-activator inhibitor type 1 and coronary artery disease. New Engl J Med 2000; 342:1792-1801.
2. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Hanney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 25:10739-10745.
3. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Nat Acad Sci USA 1995;14:1851-1855.
4. Westendorp RGJ, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999;354:561-563.
5. Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, Wang P. The plasminogen activator inhibitor-1 gene, hypofibrinolysis and osteonecrosis. Clin Orthop 1999;366:133-146.
6. Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, Kubo T, Hamaguchi H. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe pre-eclampsia. J Hum Genet 2000;45:138-141.
7. Wong TY, Poon P, Szeto CC, Chan JC, Li PK. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int 2000;57:632-638.
8. Zoller B, Garcia de Frutos P, Dahlback B. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost 1998;79:802-807.
9. Doggen CJM, Bertina RM, Manger Cats V, Reitsma PH, Rosendaal FR. The 4G/SG polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 1999;82:115-120.
10. Hooper WC, Lally C, Austin H, Renshaw M, Dilley A, Wenger NK, Philips DJ, Whitsett C, Rawlins P, Evatt BL. The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 2000;1:223-230.
11. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van den Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
12. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
13. Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimaki T. Plasminogen activator inhibitor 1 gene and risk of MS in women. Neurology 2000;9:1862-1864.
14. Roest M, van der Schouw YT, Banga JD, Tempelman MJ, de Groot PG, Sixma JJ, Grobbee DE. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 2000;101:67-70.
15. Akar N, Yilmaz E, Akar E, Avcu F, Yalcin A, Cin S. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A. Thromb Res 2000;15:227-230.
16. Segui R, Estelles A, Mira Y, Espana F, Villa P, Falco C, Vaya A, Grancha S, Ferrando F, Aznar J. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Hematol 2000;111:122-128.